Literature DB >> 12003164

Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly persons.

Takashi Kanbayashi1, Tamami Yano, Hideaki Ishiguro, Kentoh Kawanishi, Shigeru Chiba, Rika Aizawa, Yukio Sawaishi, Kouichi Hirota, Seiji Nishino, Tetsuo Shimizu.   

Abstract

STUDY
OBJECTIVES: Recent CSF and postmortem brain hypocretin measurements in human narcolepsy suggest that hypocretin deficiency is involved in the pathophysiology of the disease. In this study, we measured CSF hypocretin-1 levels in various age ranges from infants to elder people to investigate the age-dependent change of hypocretin concentrations.
DESIGN: CSF hypocretin levels were compared by age groups and gender. ANOVA was used to examine the influences of these two parameters on CSF hypocretin levels.
SETTING: University-based sleep and biology laboratory. PATIENTS OR PARTICIPANTS: Two hundred seventy two patients were included in this study, with 157 males and 115 females (0-79 years old).
INTERVENTIONS: CSF samples were obtained by lumber punctures with informed consents. MEASUREMENTS AND
RESULTS: Hypocretin-1 levels are not different in respect to gender or age, although our samples constitute a heterogeneous group with various disease conditions. CSF hypocretin-1 levels in infants under 4 months are similar to those in adults.
CONCLUSIONS: Early maturation of hypocretin transmission is suggested. No age- or gender-dependent changes in CSF hypocretin is observed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003164     DOI: 10.1093/sleep/25.3.337

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  11 in total

1.  The emerging role of hypocretin (orexin-A) in the developing central nervous system.

Authors:  Suresh Kotagal
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

Review 2.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

3.  CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans.

Authors:  Adi Aran; Irina Shors; Ling Lin; Emmanuel Mignot; Michael S Schimmel
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

Review 4.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

5.  The diurnal rhythm of hypocretin in young and old F344 rats.

Authors:  Frank Desarnaud; Eric Murillo-Rodriguez; Ling Lin; Man Xu; Dmitry Gerashchenko; Samara N Shiromani; Seiji Nishino; Emmanuel Mignot; Priyattam J Shiromani
Journal:  Sleep       Date:  2004-08-01       Impact factor: 5.849

6.  Genome-wide analysis of CNV (copy number variation) and their associations with narcolepsy in a Japanese population.

Authors:  Maria Yamasaki; Taku Miyagawa; Hiromi Toyoda; Seik-Soon Khor; Asako Koike; Aino Nitta; Kumi Akiyama; Tsukasa Sasaki; Yutaka Honda; Makoto Honda; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2014-04-03       Impact factor: 3.172

Review 7.  The hypocretin/orexin system.

Authors:  I O Ebrahim; R S Howard; M D Kopelman; M K Sharief; A J Williams
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 18.000

Review 8.  Neurobiology and sleep disorders in cluster headache.

Authors:  Mads Christian Johannes Barloese
Journal:  J Headache Pain       Date:  2015-08-20       Impact factor: 7.277

9.  Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness.

Authors:  Yuki Omori; Takashi Kanbayashi; Aya Imanishi; Ko Tsutsui; Yohei Sagawa; Yuka S Kikuchi; Masahiro Takeshima; Kazuhisa Yoshizawa; Sachiko Uemura; Tetsuo Shimizu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-02-08       Impact factor: 2.570

10.  Early detection of Niemann-pick disease type C with cataplexy and orexin levels: continuous observation with and without Miglustat.

Authors:  A Imanishi; T Kawazoe; Y Hamada; T Kumagai; K Tsutsui; N Sakai; K Eto; A Noguchi; T Shimizu; T Takahashi; G Han; K Mishima; T Kanbayashi; H Kondo
Journal:  Orphanet J Rare Dis       Date:  2020-09-29       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.